G

GT Medical Technologies

HealthUnited States· B2B

GT Medical Technologies develops innovative treatments for brain tumor patients, focusing on improving survival outcomes and quality of life. Their flagship product, GammaTile therapy, delivers immediate targeted radiation at the tumor site during surgery, aiming to reduce tumor regrowth and limit exposure to healthy brain tissue.

$100M · Series EVisit website ↗

🏆 Featured in Datapile’s Q2 2026 USA Funding Report

Read the Q2 2026 USA report →
Add this badge to your site
Featured in Datapile’s Q2 2026 USA Funding Report
<a href="https://datapile.co/reports/q2-2026-usa-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q2 2026 USA Funding Report</a>

Funding history

  1. $100MSeries E2026-06-09
    Source: news.google.com ↗

Investors in GT Medical Technologies

Backers from this company's tracked funding rounds.

  • Viking Global Investors
  • MVM Partners
  • Gilde Healthcare
  • Evidity Health Capital
  • Medtech Venture Partners
  • FemHealth Ventures

More Health companies

Recently funded startups in the same category.

Related on Datapile